{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:46:00Z","timestamp":1780598760728,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA220937"],"award-info":[{"award-number":["CA220937"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA016058"],"award-info":[{"award-number":["CA016058"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The pancreatic acinar-enriched miR-216a, miR-216b and miR-217 are encoded within the miR217HG. These miRNAs have been purported to play a tumor suppressive role as their expression is reduced in both human and mouse pancreatic ductal adenocarcinoma (PDAC). To examine this possibility, we generated individual, germline knockout (KO) mice of miR-216a, miR-216b or miR-217. Unlike our previous study showing germline deletion of the miR217HG was embryonic lethal, CRISPR-Cas9 deleted portions of the 5\u2019 seed region of the miRNAs produced live births. To investigate possible phenotypes during pancreatic acinar ductal metaplasia (ADM), pancreatic acini from wild type and KO mice were plated on collagen and allowed to transdifferentiate over 4 days. Acini from each of the three miRNA KO mice produced greater numbers of ducts compared to controls. Evaluation of the gene expression during <jats:italic>in vitro<\/jats:italic> ADM demonstrated an increase in Krt19 and a reduction in acinar genes (Carboxypeptidase A1, Amylase2a) on day 4 of the transdifferentiation. Recovery was delayed for the miR-216a and miR-216b KOs following caerulein-induced acute pancreatitis. Also predominate in the caerulein treated miR-216a and miR-216b KO mice was the presence of pancreatic duct glands (PDGs). To further establish a phenotype, miRNA KO mice were crossed with EL-<jats:italic>KRAS<\/jats:italic><jats:sup>G12D<\/jats:sup> (EK) mice and followed up to 13 months of age. While all mice developed severe dysplasia and cystic papillary neoplasms, there existed no apparent phenotypic difference in the miRNA KO\/EK mice compared to EK mice. Our data does not support a tumor suppressor role for miR-216a, miR-216b or miR-217 in PDAC and emphasizes the need for phenotypic evaluation of miRNAs in complex <jats:italic>in vivo<\/jats:italic> models beyond that performed using cell culture.<\/jats:p>","DOI":"10.1038\/s41598-019-47566-x","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T10:02:32Z","timestamp":1564567352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Dhruvitkumar S.","family":"Sutaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara","family":"Azevedo-Pouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristianna","family":"Fredenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-7086","authenticated-orcid":false,"given":"Georgina","family":"Mancinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Grippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Schmittgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"47566_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74, 2913\u20132921 (2014).","journal-title":"Cancer Res"},{"key":"47566_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J Clin 69, 7\u201334 (2019).","journal-title":"CA Cancer J Clin"},{"key":"47566_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/ijc.27322","volume":"131","author":"PJ Grippo","year":"2012","unstructured":"Grippo, P. J. & Sandgren, E. P. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents. Int J Cancer 131, 1243\u20131248 (2012).","journal-title":"Int J Cancer"},{"key":"47566_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ccr.2007.01.012","volume":"11","author":"C Guerra","year":"2007","unstructured":"Guerra, C. et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11, 291\u2013302 (2007).","journal-title":"Cancer Cell"},{"key":"47566_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2007.02.020","volume":"11","author":"LC Murtaugh","year":"2007","unstructured":"Murtaugh, L. C. & Leach, S. D. A case of mistaken identity? Nonductal origins of pancreatic \u201cductal\u201d cancers. Cancer Cell 11, 211\u2013213 (2007).","journal-title":"Cancer Cell"},{"key":"47566_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1053\/j.gastro.2013.01.074","volume":"144","author":"BZ Stanger","year":"2013","unstructured":"Stanger, B. Z. & Hebrok, M. Control of cell identity in pancreas development and regeneration. Gastroenterology 144, 1170\u20131179 (2013).","journal-title":"Gastroenterology"},{"key":"47566_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jcmgh.2016.09.009","volume":"3","author":"CJ Halbrook","year":"2017","unstructured":"Halbrook, C. J. et al. Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis. Cell Mol Gastroenterol Hepatol 3, 99\u2013118 (2017).","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"47566_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7200","volume":"6","author":"GY Liou","year":"2015","unstructured":"Liou, G. Y. et al. Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia. Nat Commun 6, 6200 (2015).","journal-title":"Nat Commun"},{"key":"47566_CR9","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice. Elife 6 (2017).","DOI":"10.7554\/eLife.27388"},{"key":"47566_CR10","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.297.17.1901","volume":"297","author":"M Bloomston","year":"2007","unstructured":"Bloomston, M. et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297, 1901\u20131908 (2007).","journal-title":"JAMA"},{"key":"47566_CR11","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/ijc.22394","volume":"120","author":"EJ Lee","year":"2007","unstructured":"Lee, E. J. et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120, 1046\u20131054 (2007).","journal-title":"Int. J. Cancer"},{"key":"47566_CR12","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1038\/sj.onc.1210228","volume":"26","author":"AE Szafranska","year":"2007","unstructured":"Szafranska, A. E. et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26, 4442\u20134452 (2007).","journal-title":"Oncogene"},{"key":"47566_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nmeth843","volume":"3","author":"WP Kloosterman","year":"2006","unstructured":"Kloosterman, W. P., Wienholds, E., de Bruijn, E., Kauppinen, S. & Plasterk, R. H. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods 3, 27\u201329 (2006).","journal-title":"Nat Methods"},{"key":"47566_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-8-166","volume":"8","author":"Y Liang","year":"2007","unstructured":"Liang, Y., Ridzon, D., Wong, L. & Chen, C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8, 166 (2007).","journal-title":"BMC Genomics"},{"key":"47566_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2220\/biomedres.34.179","volume":"34","author":"K Endo","year":"2013","unstructured":"Endo, K., Weng, H., Kito, N., Fukushima, Y. & Iwai, N. MiR-216a and miR-216b as markers for acute phased pancreatic injury. Biomedical research 34, 179\u2013188 (2013).","journal-title":"Biomedical research"},{"key":"47566_CR16","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00109-017-1571-z","volume":"95","author":"A Majumdar","year":"2017","unstructured":"Majumdar, A. et al. miR-217-casein kinase-2 cross talk regulates ERK activation in ganglioglioma. Journal of molecular medicine 95, 1215\u20131226 (2017).","journal-title":"Journal of molecular medicine"},{"key":"47566_CR17","doi-asserted-by":"publisher","first-page":"465479","DOI":"10.1155\/2015\/465479","volume":"2015","author":"N Kito","year":"2015","unstructured":"Kito, N., Endo, K., Ikesue, M., Weng, H. & Iwai, N. miRNA Profiles of Tubular Cells: Diagnosis of Kidney Injury. Biomed Res Int 2015, 465479 (2015).","journal-title":"Biomed Res Int"},{"key":"47566_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.canlet.2014.08.007","volume":"355","author":"S Deng","year":"2014","unstructured":"Deng, S. et al. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway. Cancer Lett 355, 184\u2013191 (2014).","journal-title":"Cancer Lett"},{"key":"47566_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/1354750X.2014.944217","volume":"19","author":"D Goodwin","year":"2014","unstructured":"Goodwin, D. et al. Evaluation of miR-216a and miR-217 as potential biomarkers of acute pancreatic injury in rats and mice. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals 19, 517\u2013529 (2014).","journal-title":"Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals"},{"key":"47566_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13000-015-0272-6","volume":"10","author":"P Vychytilova-Faltejskova","year":"2015","unstructured":"Vychytilova-Faltejskova, P. et al. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma. Diagn Pathol 10, 38 (2015).","journal-title":"Diagn Pathol"},{"key":"47566_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.7150\/ijms.18641","volume":"14","author":"X Chang","year":"2017","unstructured":"Chang, X., Yu, C., Li, J., Yu, S. & Chen, J. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms. Int J Med Sci 14, 412\u2013418 (2017).","journal-title":"Int J Med Sci"},{"key":"47566_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1158\/1078-0432.CCR-11-2347","volume":"18","author":"J Yu","year":"2012","unstructured":"Yu, J., Li, A., Hong, S. M., Hruban, R. H. & Goggins, M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 18, 981\u2013992 (2012).","journal-title":"Clin Cancer Res"},{"issue":"2-3","key":"47566_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10142-016-0512-1","volume":"17","author":"Ana Clara P. Azevedo-Pouly","year":"2016","unstructured":"Azevedo-Pouly, A. C. et al. miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216\/miR-217 host gene is embryonic lethal. Funct Integr Genomics 17, 203\u2013212 (2016).","journal-title":"Functional & Integrative Genomics"},{"key":"47566_CR24","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/modpathol.2012.122","volume":"25","author":"NA Schultz","year":"2012","unstructured":"Schultz, N. A. et al. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod Pathol 25, 1609\u20131622 (2012).","journal-title":"Mod Pathol"},{"key":"47566_CR25","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1172\/JCI63539","volume":"122","author":"SH Hsu","year":"2012","unstructured":"Hsu, S. H. et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122, 2871\u20132883 (2012).","journal-title":"J Clin Invest"},{"key":"47566_CR26","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1172\/JCI63455","volume":"122","author":"WC Tsai","year":"2012","unstructured":"Tsai, W. C. et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 122, 2884\u20132897 (2012).","journal-title":"J Clin Invest"},{"key":"47566_CR27","first-page":"2366","volume":"119","author":"R Taulli","year":"2009","unstructured":"Taulli, R. et al. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 119, 2366\u20132378 (2009).","journal-title":"J Clin Invest"},{"key":"47566_CR28","first-page":"1321","volume-title":"Archives of medical science: AMS","author":"X Wu","year":"2018","unstructured":"Wu, X. et al. MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS. Archives of medical science: AMS 14, (1321\u20131332 (2018)."},{"key":"47566_CR29","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/carcin\/bgq160","volume":"31","author":"WG Zhao","year":"2010","unstructured":"Zhao, W. G. et al. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 31, 1726\u20131733 (2010).","journal-title":"Carcinogenesis"},{"key":"47566_CR30","doi-asserted-by":"publisher","first-page":"53180","DOI":"10.18632\/oncotarget.18261","volume":"8","author":"T Idichi","year":"2017","unstructured":"Idichi, T. et al. Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma. Oncotarget 8, 53180\u201353193 (2017).","journal-title":"Oncotarget"},{"key":"47566_CR31","first-page":"4050","volume":"21","author":"J Yang","year":"2017","unstructured":"Yang, J., Zhang, H. F. & Qin, C. F. MicroRNA-217 functions as a prognosis predictor and inhibits pancreatic cancer cell proliferation and invasion via targeting E2F3. Eur Rev Med Pharmacol Sci 21, 4050\u20134057 (2017).","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"47566_CR32","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.febslet.2015.06.036","volume":"589","author":"BH Hou","year":"2015","unstructured":"Hou, B. H. et al. miR-216a may inhibit pancreatic tumor growth by targeting JAK2. FEBS Lett 589, 2224\u20132232 (2015).","journal-title":"FEBS Lett"},{"key":"47566_CR33","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.7150\/jca.18931","volume":"8","author":"Y You","year":"2017","unstructured":"You, Y. et al. MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells. J Cancer 8, 2854\u20132865 (2017).","journal-title":"J Cancer"},{"key":"47566_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05274-4","volume":"7","author":"P Liu","year":"2017","unstructured":"Liu, P. et al. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma. Sci Rep 7, 5186 (2017).","journal-title":"Sci Rep"},{"key":"47566_CR35","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","volume":"153","author":"H Wang","year":"2013","unstructured":"Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering. Cell 153, 910\u2013918 (2013).","journal-title":"Cell"},{"key":"47566_CR36","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.cell.2013.08.022","volume":"154","author":"H Yang","year":"2013","unstructured":"Yang, H. et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR\/Cas-mediated genome engineering. Cell 154, 1370\u20131379 (2013).","journal-title":"Cell"},{"key":"47566_CR37","doi-asserted-by":"crossref","unstructured":"Azevedo-Pouly, A. C., Elgamal, O. A. & Schmittgen, T. D. RNA isolation from mouse pancreas: a ribonuclease-rich tissue. Journal of visualized experiments: JoVE, e51779 (2014).","DOI":"10.3791\/51779"},{"key":"47566_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ymeth.2007.09.006","volume":"44","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. et al. Real-time PCR quantification of precursor and mature microRNA. Methods 44, 31\u201338 (2008).","journal-title":"Methods"},{"key":"47566_CR39","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/onc.2012.210","volume":"32","author":"G Shi","year":"2013","unstructured":"Shi, G. et al. Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. Oncogene 32, 1950\u20131958 (2013).","journal-title":"Oncogene"},{"key":"47566_CR40","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1053\/j.gastro.2009.12.005","volume":"138","author":"O Strobel","year":"2010","unstructured":"Strobel, O. et al. Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia. Gastroenterology 138, 1166\u20131177 (2010).","journal-title":"Gastroenterology"},{"key":"47566_CR41","first-page":"2016","volume":"63","author":"PJ Grippo","year":"2003","unstructured":"Grippo, P. J., Nowlin, P. S., Demeure, M. J., Longnecker, D. S. & Sandgren, E. P. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res 63, 2016\u20132019 (2003).","journal-title":"Cancer Res"},{"key":"47566_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/jhg.2016.59","volume":"62","author":"K Yonemori","year":"2017","unstructured":"Yonemori, K., Kurahara, H., Maemura, K. & Natsugoe, S. MicroRNA in pancreatic cancer. J Hum Genet 62, 33\u201340 (2017).","journal-title":"J Hum Genet"},{"key":"47566_CR43","doi-asserted-by":"crossref","unstructured":"Park, J. K., Doseff, A. I. & Schmittgen, T. D. MicroRNAs Targeting Caspase-3 and -7 in PANC-1 Cells. Int J Mol Sci 19 (2018).","DOI":"10.3390\/ijms19041206"},{"key":"47566_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbrc.2011.02.065","volume":"406","author":"JK Park","year":"2011","unstructured":"Park, J. K. et al. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun 406, 518\u2013523 (2011).","journal-title":"Biochem Biophys Res Commun"},{"key":"47566_CR45","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1097\/MPA.0b013e3181ba82e1","volume":"38","author":"JK Park","year":"2009","unstructured":"Park, J. K., Lee, E. J., Esau, C. & Schmittgen, T. D. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas 38, e190\u2013199 (2009).","journal-title":"Pancreas"},{"key":"47566_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fonc.2017.00101","volume":"7","author":"J Dooley","year":"2017","unstructured":"Dooley, J. et al. No Functional Role for microRNA-342 in a Mouse Model of Pancreatic Acinar Carcinoma. Front Oncol 7, 101 (2017).","journal-title":"Front Oncol"},{"key":"47566_CR47","doi-asserted-by":"publisher","first-page":"21686","DOI":"10.1074\/jbc.M111.328054","volume":"287","author":"J Bao","year":"2012","unstructured":"Bao, J. et al. MicroRNA-449 and microRNA-34b\/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway. J Biol Chem 287, 21686\u201321698 (2012).","journal-title":"J Biol Chem"},{"key":"47566_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.424","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment induced by Reg3g overexpression. Cell Death Dis 8, e3033 (2017).","journal-title":"Cell Death Dis"},{"key":"47566_CR49","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1007\/s10620-015-3787-5","volume":"60","author":"G Yin","year":"2015","unstructured":"Yin, G. et al. Reg3g Promotes Pancreatic Carcinogenesis in a Murine Model of Chronic Pancreatitis. Dig Dis Sci 60, 3656\u20133668 (2015).","journal-title":"Dig Dis Sci"},{"key":"47566_CR50","doi-asserted-by":"crossref","first-page":"77838","DOI":"10.18632\/oncotarget.12834","volume":"7","author":"Q Li","year":"2016","unstructured":"Li, Q. et al. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma. Oncotarget 7, 77838\u201377853 (2016).","journal-title":"Oncotarget"},{"key":"47566_CR51","doi-asserted-by":"publisher","first-page":"e95486","DOI":"10.1371\/journal.pone.0095486","volume":"9","author":"JPT Morris","year":"2014","unstructured":"Morris, J. P. T. et al. Dicer regulates differentiation and viability during mouse pancreatic cancer initiation. PLoS One 9, e95486 (2014).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47566-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:11:32Z","timestamp":1671279092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47566-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47566"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47566-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"6 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11147"}}